Literature DB >> 23695056

Refractory migraine: the role of the physician in assessment and treatment of a problematic disease.

Bruno Colombo1, Dacia Dalla Libera, Gloria Dalla Costa, Giancarlo Comi.   

Abstract

Patients affected by chronic forms of headache are often very difficult to treat. Refractory patients are so defined when adequate trials of specific drugs (for acute or prophylactic treatment) failed both to reduce the burden of disease and to improve headache-related quality of life. An escalating approach is suggested to test different kinds of therapies. All comorbid factors should be addressed. More invasive modalities (such as neurostimulation) or promising approaches such as repetitive transcranial magnetic stimulation (rTMS) could be a future major step as third line therapies.

Entities:  

Mesh:

Year:  2013        PMID: 23695056     DOI: 10.1007/s10072-013-1385-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  12 in total

Review 1.  Neurostimulation therapies for primary headache disorders: present and future.

Authors:  Delphine Magis; Rigmor Jensen; Jean Schoenen
Journal:  Curr Opin Neurol       Date:  2012-06       Impact factor: 5.710

Review 2.  Drug-resistant chronic migraine: the Italian GON project.

Authors:  A Proietti Cecchini; M Leone; G C Manzoni; P Torelli; G Bussone
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

3.  A rational approach to the management of chronic migraine.

Authors:  Randolph W Evans
Journal:  Headache       Date:  2013-01       Impact factor: 5.887

Review 4.  Diaries and calendars for migraine. A review.

Authors:  G Nappi; R Jensen; R E Nappi; G Sances; P Torelli; J Olesen
Journal:  Cephalalgia       Date:  2006-08       Impact factor: 6.292

5.  Current concepts in refractory migraine.

Authors:  Elliott Schulman; Brian E McGeeney
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

Review 6.  Defining the pharmacologically intractable headache for clinical trials and clinical practice.

Authors:  Stephen D Silberstein; David W Dodick; Starr Pearlman
Journal:  Headache       Date:  2010-10       Impact factor: 5.887

Review 7.  Beyond neurovascular: migraine as a dysfunctional neurolimbic pain network.

Authors:  Morris Maizels; Sheena Aurora; Mary Heinricher
Journal:  Headache       Date:  2012-07-03       Impact factor: 5.887

8.  Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society.

Authors:  Elliott A Schulman; Alvin E Lake; Peter J Goadsby; B Lee Peterlin; Sherry E Siegel; Herbert G Markley; Richard B Lipton
Journal:  Headache       Date:  2008-05-14       Impact factor: 5.887

Review 9.  When should "chronic migraine" patients be considered "refractory" to pharmacological prophylaxis?

Authors:  Domenico D'Amico; Massimo Leone; Licia Grazzi; Gennaro Bussone
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

10.  Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.

Authors:  Marcelo E Bigal; Daniel Serrano; Michael Reed; Richard B Lipton
Journal:  Neurology       Date:  2008-08-19       Impact factor: 9.910

View more
  2 in total

1.  Survival outcome and mortality rate in patients with migraine: a population-based cohort study.

Authors:  Tomor Harnod; Cheng-Li Lin; Chia-Hung Kao
Journal:  J Headache Pain       Date:  2018-07-25       Impact factor: 7.277

2.  Risk and Predisposing Factors for Suicide Attempts in Patients with Migraine and Status Migrainosus: A Nationwide Population-Based Study.

Authors:  Tomor Harnod; Cheng-Li Lin; Chia-Hung Kao
Journal:  J Clin Med       Date:  2018-09-11       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.